The Food and Drug Administration this week issued guidance intended to clarify the agency’s expectations when electronic health records are used as a source of data in clinical investigations. The guidance applies to clinical investigations of human drugs and biological products, medical devices and combination products, including investigations conducted in clinical practice settings.
AHA Center for Health Innovation Market Scan
Amazon has introduced a new cloud-based software service that reportedly will sift through patient medical records in seconds searching for actionable…
Joint letter from AHA and six other national hospital associations to HHS affirming hospital and health system commitment to interoperability, while stating…
Download the comment letter (PDF)
The Centers for Medicare & Medicaid Services (CMS) Aug.